SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-039629
Filing Date
2023-11-07
Accepted
2023-11-07 06:03:05
Documents
15

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 88168
2 formdefa14a_008.jpg GRAPHIC 152117
3 formdefa14a_009.jpg GRAPHIC 1052655
4 formdefa14a_010.jpg GRAPHIC 887585
5 formdefa14a_011.jpg GRAPHIC 898925
6 formdefa14a_012.jpg GRAPHIC 581971
7 formdefa14a_013.jpg GRAPHIC 1024273
8 formdefa14a_014.jpg GRAPHIC 357802
9 formdefa14a_015.jpg GRAPHIC 558850
10 formdefa14a_016.jpg GRAPHIC 388748
11 formdefa14a_017.jpg GRAPHIC 974896
12 formdefa14a_018.jpg GRAPHIC 416581
13 formdefa14a_019.jpg GRAPHIC 808873
14 formdefa14a_020.jpg GRAPHIC 242965
15 logo_001.jpg GRAPHIC 49671
  Complete submission text file 0001493152-23-039629.txt   11653178
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 231381371
SIC: 2836 Biological Products, (No Diagnostic Substances)